Peripheral Nerve Block Compared to Intra-articular Injection for TAA Post-operative Pain
NCT ID: NCT03674905
Last Updated: 2018-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
50 participants
INTERVENTIONAL
2016-11-29
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of EXPAREL vs. Bupivacaine
NCT07212114
Pre vs Post Block in Total Knee Arthroplasty (TKA)
NCT05974501
A Study to Compare the Effectiveness of Adductor Canal Pain Catheters Following Total Knee Arthroplasty
NCT05053087
Analgesia After Total Knee Arthroplasty
NCT00869037
Comparison of Two Periarticular Injection Medications for Adjunctive Pain Management Following Total Knee Arthroplasty (TKA)
NCT02060591
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients will be randomized to receive one of the following interventions for pain control in the operating room:
1. Intra-articular Injection
2. Preoperative Peripheral Nerve Block:
The study aims are:
* Aim 1: Determine if intra-articular injection as source of pain control for TAA lowers postoperative pain as measured by self-reported narcotic use and pain vs. the peripheral nerve block.
* Aim 2: Evaluate differences in functional outcomes and health related quality of life between intra-articular injections and peripheral nerve block as reported by pre- and post-operative patient questionnaires
Patients who consent to participate will complete study activities pre-operatively, and at 2 weeks, 6 weeks, and 3 months post-operatively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intra-articular injection
Intra-articular injection at the completion of TAA procedure.
Intra-articular injection
Intra-articular injection at the completion of TAA procedure.
Peripheral nerve block
Pre-operative peripheral nerve block.
Peripheral nerve block
Pre-operative peripheral nerve block.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intra-articular injection
Intra-articular injection at the completion of TAA procedure.
Peripheral nerve block
Pre-operative peripheral nerve block.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient is having a primary, unilateral TAA
* Patient has signed the current, Institutional Review Board approved informed consent document
Exclusion Criteria
* Patient has uncontrolled diabetes; lab result of hemoglobin A1c level \> 8.0 mg/dL
* Patient has significant heart, liver, kidney or respiratory disease
* Patient has peripheral vascular disease
* Patient has active cancer
* Patient has current history of narcotic use beyond that of oral medications
* Patient discharge status is known to be to care facility
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Slocum Center for Orthopedics and Sports Medicine
OTHER
Slocum Research & Education Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nicholas Strasser
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas L Strasser, MD
Role: PRINCIPAL_INVESTIGATOR
Slocum Center for Orthopedics and Sports Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Slocum Research & Education Foundation
Eugene, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NLS_TAA1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.